Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guilu Erxian Oral Liquid for Oligozoospermia and Asthenospermia
NCT07270146Phase 4Completed
- Sponsor
- Dong-E-E-Jiao
- Start
- Oct 2022
- Primary completion
- Feb 2025
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of Guilu Erxian Oral Liquid in oligozoospermia, asthenospermia, oligoasthenospermia (OA), sponsored by Dong-E-E-Jiao. Started Oct 2022; status: completed.
02
Drugs
Guilu Erxian Oral Liquid
03
Conditions
oligozoospermiaasthenospermiaoligoasthenospermia (OA)
Beyond the preview
Go deeper on NCT07270146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07270146.